Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00242372
Status:
TERMINATED
Last Update Posted:
2009-04-22
First Post:
2005-10-19
Brief Title:
GALLANT 9 Tesaglitazar vs Placebo in Combination With Insulin
Sponsor:
Organization:
AstraZeneca